Please Share:: 
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
http://www.kotaksecurities.com/pdf/dmb/MorningInsight21052012.pdf
STATE BANK OF INDIA (SBI)
PRICE: RS.1940 RECOMMENDATION: BUY
TARGET PRICE: RS.2484 FY13E P/E: 9.4X; P/ABV: 1.7x
Q4FY12: Encouraging performance; worst of asset quality is
likely behind us.
NII was strong (45.2% YoY), mainly driven by margin expansion (82bps
YoY) despite moderate loan growth (14.7% YoY). Its net profit was even
stronger at Rs.40.5 bn (194x YoY on low base), aided by lower credit
costs (decline of 57bps YoY) and marginal rise in opex (8.5% YoY) along
with robust core performance.
Although credit growth (14.7% YoY) came a tad lower than the system,
funding franchise remained strong (46.64% CASA, lower dependence on
wholesale funding). New management has been focusing more on margins as against earlier strategy of garnering market share, even if it came
at some margin sacrifice. We are modeling NIM at 3.66% during FY13E as
against 3.85% achieved during FY12.
Lower slippages (2.27% on annualized basis) along with relatively lesser
addition to restructured portfolio (Rs.51 bn) during Q4FY12 were very
encouraging. In absolute terms, both gross NPA and net NPA declined
QoQ by 1.1% and 15.9%, respectively; PCR also improved by 558bps QoQ
to 68.1% at the end of FY12, leading to improvement in B/S quality.
We have raised the earnings by ~5% for FY13 and now expect it to grow
17.7% during FY13E. We expect return profile to get better by FY13E
(RoA: ~0.9%, RoE: ~16%) and hence we maintain BUY rating on the stock
with revised TP of Rs.2484 (earlier Rs.2436) based on SOTP methodology
where core business is valued at Rs.1731 (1.5x FY13E ABV) and subsidiaries are valued at Rs.753 (after giving 20% holding company discount).
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
http://www.kotaksecurities.com/pdf/dmb/MorningInsight21052012.pdf
STATE BANK OF INDIA (SBI)
PRICE: RS.1940 RECOMMENDATION: BUY
TARGET PRICE: RS.2484 FY13E P/E: 9.4X; P/ABV: 1.7x
Q4FY12: Encouraging performance; worst of asset quality is
likely behind us.
NII was strong (45.2% YoY), mainly driven by margin expansion (82bps
YoY) despite moderate loan growth (14.7% YoY). Its net profit was even
stronger at Rs.40.5 bn (194x YoY on low base), aided by lower credit
costs (decline of 57bps YoY) and marginal rise in opex (8.5% YoY) along
with robust core performance.
Although credit growth (14.7% YoY) came a tad lower than the system,
funding franchise remained strong (46.64% CASA, lower dependence on
wholesale funding). New management has been focusing more on margins as against earlier strategy of garnering market share, even if it came
at some margin sacrifice. We are modeling NIM at 3.66% during FY13E as
against 3.85% achieved during FY12.
Lower slippages (2.27% on annualized basis) along with relatively lesser
addition to restructured portfolio (Rs.51 bn) during Q4FY12 were very
encouraging. In absolute terms, both gross NPA and net NPA declined
QoQ by 1.1% and 15.9%, respectively; PCR also improved by 558bps QoQ
to 68.1% at the end of FY12, leading to improvement in B/S quality.
We have raised the earnings by ~5% for FY13 and now expect it to grow
17.7% during FY13E. We expect return profile to get better by FY13E
(RoA: ~0.9%, RoE: ~16%) and hence we maintain BUY rating on the stock
with revised TP of Rs.2484 (earlier Rs.2436) based on SOTP methodology
where core business is valued at Rs.1731 (1.5x FY13E ABV) and subsidiaries are valued at Rs.753 (after giving 20% holding company discount).
No comments:
Post a Comment